Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ablation Techniques | 11 | 2024 | 254 | 2.360 |
Why?
|
Cryosurgery | 9 | 2024 | 479 | 2.260 |
Why?
|
Radiology, Interventional | 5 | 2021 | 484 | 2.180 |
Why?
|
Radiography, Interventional | 15 | 2018 | 1128 | 1.870 |
Why?
|
Adrenal Gland Neoplasms | 4 | 2019 | 731 | 1.470 |
Why?
|
Radiology | 6 | 2024 | 2105 | 1.460 |
Why?
|
Catheter Ablation | 12 | 2023 | 2787 | 1.250 |
Why?
|
Surgery, Computer-Assisted | 9 | 2023 | 994 | 1.200 |
Why?
|
Tomography, X-Ray Computed | 45 | 2019 | 20690 | 1.150 |
Why?
|
Microwaves | 7 | 2021 | 182 | 0.900 |
Why?
|
Kidney Neoplasms | 12 | 2023 | 4278 | 0.860 |
Why?
|
Carcinoma, Renal Cell | 10 | 2023 | 3183 | 0.810 |
Why?
|
Checklist | 2 | 2022 | 837 | 0.810 |
Why?
|
Ultrasonography, Interventional | 4 | 2013 | 1519 | 0.770 |
Why?
|
Radiography | 7 | 2023 | 6941 | 0.640 |
Why?
|
Thoracic Wall | 1 | 2019 | 196 | 0.580 |
Why?
|
Speech Recognition Software | 1 | 2017 | 74 | 0.550 |
Why?
|
Radiology Department, Hospital | 1 | 2021 | 409 | 0.550 |
Why?
|
Urolithiasis | 4 | 2019 | 123 | 0.520 |
Why?
|
Liver Neoplasms | 7 | 2021 | 4349 | 0.490 |
Why?
|
Pleural Neoplasms | 1 | 2019 | 583 | 0.480 |
Why?
|
Catecholamines | 1 | 2015 | 385 | 0.470 |
Why?
|
Diagnostic Imaging | 4 | 2018 | 3530 | 0.470 |
Why?
|
Adrenalectomy | 1 | 2015 | 344 | 0.440 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2013 | 193 | 0.430 |
Why?
|
Infection Control | 1 | 2021 | 984 | 0.430 |
Why?
|
Radiation Protection | 4 | 2015 | 424 | 0.420 |
Why?
|
Obesity | 8 | 2021 | 13082 | 0.410 |
Why?
|
Electronic Health Records | 2 | 2022 | 4863 | 0.390 |
Why?
|
Radiation Dosage | 5 | 2018 | 1945 | 0.380 |
Why?
|
Neurilemmoma | 1 | 2017 | 522 | 0.380 |
Why?
|
Embolization, Therapeutic | 4 | 2021 | 1405 | 0.370 |
Why?
|
Patient Care Planning | 1 | 2016 | 903 | 0.370 |
Why?
|
Spinal Neoplasms | 1 | 2017 | 708 | 0.350 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 5 | 2019 | 1225 | 0.340 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2018 | 958 | 0.340 |
Why?
|
Neoplasms | 5 | 2024 | 22340 | 0.330 |
Why?
|
Nephrectomy | 2 | 2018 | 927 | 0.330 |
Why?
|
Medical Oncology | 1 | 2021 | 2339 | 0.320 |
Why?
|
Transportation of Patients | 2 | 2007 | 177 | 0.320 |
Why?
|
Vena Cava Filters | 2 | 2024 | 270 | 0.310 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2009 | 76 | 0.310 |
Why?
|
Humans | 98 | 2024 | 765926 | 0.300 |
Why?
|
Injections, Intra-Articular | 1 | 2009 | 279 | 0.300 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2474 | 0.300 |
Why?
|
Bone Neoplasms | 2 | 2019 | 2559 | 0.300 |
Why?
|
Nephrolithiasis | 1 | 2009 | 117 | 0.290 |
Why?
|
Hepatectomy | 3 | 2021 | 588 | 0.280 |
Why?
|
Ureteral Obstruction | 1 | 2009 | 293 | 0.280 |
Why?
|
Tumor Burden | 3 | 2024 | 1888 | 0.260 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2661 | 0.260 |
Why?
|
Internship and Residency | 3 | 2024 | 5945 | 0.260 |
Why?
|
Palliative Care | 2 | 2021 | 3640 | 0.250 |
Why?
|
Arthralgia | 1 | 2009 | 459 | 0.250 |
Why?
|
Pain | 2 | 2019 | 5077 | 0.250 |
Why?
|
Radiographic Image Enhancement | 2 | 2009 | 873 | 0.250 |
Why?
|
Lymphatic Metastasis | 6 | 2018 | 2885 | 0.240 |
Why?
|
Urologic Diseases | 1 | 2008 | 245 | 0.240 |
Why?
|
Coronary Angiography | 2 | 2009 | 4498 | 0.240 |
Why?
|
Curriculum | 4 | 2024 | 3784 | 0.230 |
Why?
|
Steroids | 1 | 2009 | 934 | 0.230 |
Why?
|
Treatment Outcome | 19 | 2024 | 65194 | 0.230 |
Why?
|
Biopsy | 3 | 2013 | 6766 | 0.230 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2021 | 2325 | 0.230 |
Why?
|
Wounds, Nonpenetrating | 2 | 2001 | 806 | 0.230 |
Why?
|
Cerebral Angiography | 1 | 2010 | 1262 | 0.230 |
Why?
|
Aged, 80 and over | 23 | 2024 | 59496 | 0.220 |
Why?
|
Decision Making | 1 | 2018 | 3955 | 0.220 |
Why?
|
Retrospective Studies | 30 | 2024 | 81537 | 0.220 |
Why?
|
Middle Aged | 50 | 2024 | 223016 | 0.220 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9373 | 0.210 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1707 | 0.210 |
Why?
|
Fournier Gangrene | 1 | 2003 | 22 | 0.210 |
Why?
|
Anesthetics, Local | 1 | 2009 | 1004 | 0.200 |
Why?
|
Kidney Diseases | 2 | 2010 | 2100 | 0.200 |
Why?
|
Male | 56 | 2024 | 363815 | 0.200 |
Why?
|
Aged | 38 | 2024 | 171163 | 0.190 |
Why?
|
Iliac Vein | 1 | 2001 | 71 | 0.190 |
Why?
|
Preoperative Care | 2 | 2008 | 2248 | 0.180 |
Why?
|
Alloys | 1 | 2001 | 109 | 0.180 |
Why?
|
Coronary Vessel Anomalies | 1 | 2004 | 308 | 0.180 |
Why?
|
User-Computer Interface | 2 | 2017 | 1404 | 0.180 |
Why?
|
Neoplasm, Residual | 2 | 2024 | 1009 | 0.180 |
Why?
|
Brown-Sequard Syndrome | 1 | 1999 | 3 | 0.170 |
Why?
|
Intracranial Aneurysm | 1 | 2010 | 1271 | 0.170 |
Why?
|
Wounds, Stab | 1 | 1999 | 72 | 0.170 |
Why?
|
Female | 51 | 2024 | 396141 | 0.160 |
Why?
|
Pneumocephalus | 1 | 1999 | 46 | 0.160 |
Why?
|
Cholecystectomy | 1 | 2021 | 409 | 0.160 |
Why?
|
Radio Waves | 2 | 2017 | 246 | 0.160 |
Why?
|
Vascular Diseases | 3 | 2010 | 1161 | 0.160 |
Why?
|
Education, Medical, Graduate | 2 | 2024 | 2419 | 0.160 |
Why?
|
Liver Diseases | 4 | 2014 | 1304 | 0.160 |
Why?
|
Ribs | 1 | 2000 | 254 | 0.160 |
Why?
|
Device Removal | 1 | 2024 | 643 | 0.150 |
Why?
|
Tomography, Emission-Computed | 1 | 2001 | 1006 | 0.150 |
Why?
|
Models, Statistical | 3 | 2013 | 5088 | 0.150 |
Why?
|
Time Factors | 9 | 2024 | 40097 | 0.150 |
Why?
|
Intestinal Perforation | 1 | 2000 | 254 | 0.150 |
Why?
|
Ureteral Diseases | 2 | 2008 | 63 | 0.150 |
Why?
|
Drainage | 3 | 2015 | 1181 | 0.150 |
Why?
|
Neck Injuries | 1 | 1999 | 162 | 0.150 |
Why?
|
Work Simplification | 1 | 2017 | 8 | 0.150 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2001 | 280 | 0.150 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 220 | 0.150 |
Why?
|
Positron-Emission Tomography | 2 | 2013 | 6542 | 0.140 |
Why?
|
Diagnosis, Differential | 11 | 2013 | 12973 | 0.140 |
Why?
|
Hernia, Inguinal | 1 | 2000 | 224 | 0.140 |
Why?
|
Abdominal Injuries | 1 | 2000 | 362 | 0.140 |
Why?
|
Workflow | 1 | 2022 | 859 | 0.140 |
Why?
|
Prosthesis Design | 1 | 2024 | 2111 | 0.140 |
Why?
|
Osteomalacia | 1 | 2016 | 60 | 0.130 |
Why?
|
Mesenchymoma | 1 | 2016 | 50 | 0.130 |
Why?
|
Liver Transplantation | 3 | 2021 | 2418 | 0.130 |
Why?
|
Adult | 32 | 2024 | 223088 | 0.130 |
Why?
|
Electromagnetic Phenomena | 1 | 2017 | 159 | 0.130 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 1 | 2019 | 208 | 0.130 |
Why?
|
Disease Progression | 4 | 2024 | 13614 | 0.120 |
Why?
|
Catheterization, Central Venous | 1 | 2000 | 538 | 0.120 |
Why?
|
Conscious Sedation | 2 | 2010 | 533 | 0.120 |
Why?
|
Task Performance and Analysis | 1 | 2018 | 770 | 0.110 |
Why?
|
Predictive Value of Tests | 6 | 2018 | 15401 | 0.110 |
Why?
|
Urinary Calculi | 2 | 2019 | 81 | 0.110 |
Why?
|
Hydronephrosis | 3 | 2010 | 274 | 0.110 |
Why?
|
Cholangiocarcinoma | 1 | 2019 | 577 | 0.110 |
Why?
|
Glomerular Filtration Rate | 2 | 2019 | 2233 | 0.110 |
Why?
|
Brachytherapy | 1 | 2021 | 1218 | 0.110 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 723 | 0.110 |
Why?
|
Neoplasm Metastasis | 3 | 2024 | 4882 | 0.100 |
Why?
|
Contrast Media | 7 | 2012 | 5330 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 9 | 2017 | 36547 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 2001 | 0.100 |
Why?
|
Pain Measurement | 2 | 2019 | 3558 | 0.100 |
Why?
|
Education, Medical, Continuing | 1 | 2018 | 829 | 0.100 |
Why?
|
Thoracic Vertebrae | 1 | 2017 | 614 | 0.100 |
Why?
|
Neoplasm Staging | 6 | 2019 | 11196 | 0.100 |
Why?
|
Pelvic Neoplasms | 1 | 2014 | 248 | 0.100 |
Why?
|
Acidosis, Lactic | 1 | 2013 | 144 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2011 | 61 | 0.090 |
Why?
|
ROC Curve | 1 | 2019 | 3612 | 0.090 |
Why?
|
Phlebography | 2 | 2024 | 326 | 0.090 |
Why?
|
Neoplasm Invasiveness | 2 | 2018 | 3599 | 0.090 |
Why?
|
Program Development | 1 | 2017 | 1297 | 0.090 |
Why?
|
Uterine Artery | 1 | 2010 | 29 | 0.090 |
Why?
|
Barium Sulfate | 2 | 2008 | 180 | 0.090 |
Why?
|
Information Dissemination | 1 | 2019 | 1142 | 0.090 |
Why?
|
Lymphangioma, Cystic | 1 | 2010 | 34 | 0.090 |
Why?
|
Lymphangiectasis | 1 | 2010 | 20 | 0.090 |
Why?
|
Risk Factors | 8 | 2024 | 74850 | 0.090 |
Why?
|
Pulmonary Embolism | 1 | 2024 | 2596 | 0.090 |
Why?
|
Fluoroscopy | 2 | 2008 | 945 | 0.090 |
Why?
|
Catheterization | 1 | 2015 | 1426 | 0.080 |
Why?
|
Angiomyolipoma | 1 | 2011 | 189 | 0.080 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1293 | 0.080 |
Why?
|
Equipment Design | 1 | 2018 | 3490 | 0.080 |
Why?
|
Angiography | 4 | 2008 | 1589 | 0.080 |
Why?
|
Survival Analysis | 2 | 2019 | 10086 | 0.080 |
Why?
|
Stents | 1 | 2001 | 3191 | 0.080 |
Why?
|
Polycythemia | 1 | 2010 | 124 | 0.080 |
Why?
|
Lymphoma | 1 | 2018 | 1896 | 0.080 |
Why?
|
Biliary Tract Diseases | 1 | 2010 | 160 | 0.080 |
Why?
|
Liver Abscess | 1 | 2009 | 81 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2022 | 3799 | 0.070 |
Why?
|
Ferrosoferric Oxide | 1 | 2009 | 349 | 0.070 |
Why?
|
Radiography, Abdominal | 2 | 2009 | 543 | 0.070 |
Why?
|
Lactic Acid | 1 | 2013 | 1137 | 0.070 |
Why?
|
Glomerulonephritis | 1 | 2010 | 331 | 0.070 |
Why?
|
Prognosis | 2 | 2019 | 29890 | 0.070 |
Why?
|
Iopamidol | 1 | 2008 | 188 | 0.070 |
Why?
|
Anesthesia, Local | 1 | 2010 | 276 | 0.070 |
Why?
|
Soft Tissue Neoplasms | 1 | 2016 | 1163 | 0.070 |
Why?
|
Carcinoma, Small Cell | 1 | 2010 | 420 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2014 | 822 | 0.070 |
Why?
|
Paraproteinemias | 1 | 2010 | 251 | 0.070 |
Why?
|
Body Mass Index | 3 | 2021 | 13042 | 0.070 |
Why?
|
Pilot Projects | 2 | 2019 | 8724 | 0.070 |
Why?
|
Patient Positioning | 1 | 2010 | 329 | 0.070 |
Why?
|
Kidney Glomerulus | 1 | 2010 | 567 | 0.070 |
Why?
|
Dextrans | 1 | 2009 | 570 | 0.070 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2009 | 264 | 0.070 |
Why?
|
Urinary Catheterization | 1 | 2008 | 195 | 0.070 |
Why?
|
Biliary Tract | 1 | 2008 | 137 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3430 | 0.070 |
Why?
|
Hypercalcemia | 1 | 2010 | 425 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2018 | 3447 | 0.070 |
Why?
|
Esophagogastric Junction | 1 | 2009 | 350 | 0.070 |
Why?
|
Postpartum Hemorrhage | 1 | 2010 | 275 | 0.070 |
Why?
|
Clinical Competence | 2 | 2024 | 4855 | 0.070 |
Why?
|
Survival Rate | 2 | 2019 | 12822 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4130 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2018 | 2307 | 0.070 |
Why?
|
Risk Assessment | 5 | 2021 | 24275 | 0.070 |
Why?
|
Technology Assessment, Biomedical | 1 | 2009 | 312 | 0.060 |
Why?
|
Melanoma | 1 | 2024 | 5695 | 0.060 |
Why?
|
Combined Modality Therapy | 4 | 2024 | 8522 | 0.060 |
Why?
|
Metformin | 1 | 2013 | 904 | 0.060 |
Why?
|
Emergency Treatment | 1 | 2009 | 494 | 0.060 |
Why?
|
Ureter | 1 | 2008 | 364 | 0.060 |
Why?
|
Posture | 1 | 2009 | 955 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12529 | 0.060 |
Why?
|
Communication | 1 | 2019 | 3908 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2013 | 2027 | 0.060 |
Why?
|
Abdominal Pain | 4 | 2013 | 1069 | 0.060 |
Why?
|
Cold Temperature | 1 | 2008 | 793 | 0.060 |
Why?
|
Equipment and Supplies | 1 | 2007 | 273 | 0.060 |
Why?
|
Sirolimus | 1 | 2011 | 1541 | 0.060 |
Why?
|
Decompression, Surgical | 1 | 2009 | 602 | 0.060 |
Why?
|
Intestinal Obstruction | 1 | 2008 | 433 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5333 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5364 | 0.050 |
Why?
|
Adolescent | 10 | 2018 | 88811 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3834 | 0.050 |
Why?
|
Radiopharmaceuticals | 1 | 2013 | 2701 | 0.050 |
Why?
|
Odds Ratio | 1 | 2015 | 9656 | 0.050 |
Why?
|
Tuberous Sclerosis | 1 | 2011 | 1039 | 0.050 |
Why?
|
Logistic Models | 2 | 2015 | 13273 | 0.050 |
Why?
|
Cardiovascular Diseases | 1 | 2009 | 15645 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5691 | 0.050 |
Why?
|
Electroporation | 1 | 2023 | 238 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2008 | 8924 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12059 | 0.050 |
Why?
|
Scrotum | 1 | 2003 | 117 | 0.050 |
Why?
|
Tissue Plasminogen Activator | 1 | 2008 | 1164 | 0.050 |
Why?
|
Delaware | 1 | 2001 | 13 | 0.050 |
Why?
|
Radiology Information Systems | 1 | 2006 | 535 | 0.050 |
Why?
|
Child, Preschool | 4 | 2017 | 42510 | 0.050 |
Why?
|
Intestine, Small | 1 | 2008 | 1216 | 0.050 |
Why?
|
Colon | 1 | 2009 | 1796 | 0.050 |
Why?
|
Placenta | 1 | 2010 | 1726 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 1 | 2008 | 1429 | 0.050 |
Why?
|
Kidney | 3 | 2013 | 7073 | 0.050 |
Why?
|
Maxillary Artery | 1 | 2000 | 18 | 0.040 |
Why?
|
Pandemics | 1 | 2021 | 8721 | 0.040 |
Why?
|
Vena Cava, Inferior | 1 | 2024 | 463 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2003 | 462 | 0.040 |
Why?
|
Sensitivity and Specificity | 5 | 2015 | 14643 | 0.040 |
Why?
|
Pelvis | 2 | 2018 | 737 | 0.040 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2844 | 0.040 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2007 | 789 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1284 | 0.040 |
Why?
|
Endoscopy | 1 | 2010 | 1854 | 0.040 |
Why?
|
Colon, Sigmoid | 1 | 2000 | 124 | 0.040 |
Why?
|
Synovial Cyst | 1 | 1999 | 33 | 0.040 |
Why?
|
Epistaxis | 1 | 2000 | 119 | 0.040 |
Why?
|
Carotid Artery, Common | 1 | 2000 | 172 | 0.040 |
Why?
|
Hepatitis C | 1 | 2010 | 1596 | 0.040 |
Why?
|
Rupture, Spontaneous | 2 | 2010 | 360 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6838 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2000 | 510 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2024 | 594 | 0.040 |
Why?
|
Young Adult | 7 | 2019 | 59857 | 0.040 |
Why?
|
Creatinine | 2 | 2018 | 1916 | 0.040 |
Why?
|
Paraganglioma | 1 | 2000 | 142 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2009 | 1659 | 0.040 |
Why?
|
Image Enhancement | 1 | 2009 | 2857 | 0.040 |
Why?
|
Vascular Neoplasms | 1 | 2000 | 167 | 0.040 |
Why?
|
Fibrinolytic Agents | 1 | 2008 | 2076 | 0.040 |
Why?
|
Retroperitoneal Space | 1 | 2018 | 175 | 0.040 |
Why?
|
Nanoparticles | 1 | 2009 | 1966 | 0.040 |
Why?
|
Arteriovenous Malformations | 1 | 2000 | 397 | 0.040 |
Why?
|
Equipment Failure | 1 | 2000 | 580 | 0.040 |
Why?
|
United States | 2 | 2021 | 72909 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2001 | 13446 | 0.030 |
Why?
|
Health Facilities | 1 | 2021 | 577 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 2010 | 2970 | 0.030 |
Why?
|
Glucose | 1 | 2008 | 4335 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 2000 | 1985 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39228 | 0.030 |
Why?
|
Linear Models | 1 | 2006 | 5873 | 0.030 |
Why?
|
Edema | 2 | 2010 | 759 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2019 | 536 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2018 | 684 | 0.030 |
Why?
|
Hemorrhage | 1 | 2008 | 3466 | 0.030 |
Why?
|
Thigh | 1 | 2016 | 236 | 0.030 |
Why?
|
Leiomyoma | 1 | 2000 | 644 | 0.030 |
Why?
|
Spinal Diseases | 1 | 1999 | 561 | 0.030 |
Why?
|
Pancreas | 2 | 2013 | 1698 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2007 | 2176 | 0.030 |
Why?
|
Venous Thrombosis | 1 | 2024 | 1319 | 0.030 |
Why?
|
Inguinal Canal | 1 | 2014 | 71 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3049 | 0.030 |
Why?
|
Reoperation | 2 | 2018 | 4308 | 0.030 |
Why?
|
Ultrasonography | 3 | 2013 | 5987 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 1999 | 978 | 0.030 |
Why?
|
Mesentery | 1 | 2014 | 200 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2010 | 4904 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7473 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2018 | 5300 | 0.030 |
Why?
|
Indocyanine Green | 1 | 2014 | 234 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2018 | 1435 | 0.030 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2012 | 110 | 0.020 |
Why?
|
Liver | 1 | 2008 | 7559 | 0.020 |
Why?
|
Coloring Agents | 1 | 2014 | 562 | 0.020 |
Why?
|
Spinal Cord Injuries | 1 | 1999 | 928 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2009 | 6360 | 0.020 |
Why?
|
Spinal Cord | 1 | 1999 | 1786 | 0.020 |
Why?
|
Uterine Neoplasms | 1 | 2000 | 1425 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2018 | 1272 | 0.020 |
Why?
|
Vulvar Neoplasms | 1 | 2014 | 265 | 0.020 |
Why?
|
Observer Variation | 2 | 2008 | 2611 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3940 | 0.020 |
Why?
|
Confusion | 1 | 2013 | 278 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1609 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 2016 | 871 | 0.020 |
Why?
|
Lung | 1 | 2009 | 10046 | 0.020 |
Why?
|
Suicide, Attempted | 1 | 1999 | 1412 | 0.020 |
Why?
|
Hospitals | 1 | 2024 | 3886 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5450 | 0.020 |
Why?
|
Ascitic Fluid | 1 | 2010 | 189 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6503 | 0.020 |
Why?
|
Child | 5 | 2018 | 80568 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 1999 | 1878 | 0.020 |
Why?
|
Vomiting | 1 | 2013 | 646 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2006 | 14745 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2009 | 6958 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2007 | 7423 | 0.020 |
Why?
|
Infant | 3 | 2008 | 36426 | 0.020 |
Why?
|
Boston | 2 | 2015 | 9334 | 0.020 |
Why?
|
Body Size | 1 | 2012 | 460 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2013 | 2476 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2015 | 20133 | 0.020 |
Why?
|
Mesenteric Artery, Superior | 1 | 2008 | 95 | 0.020 |
Why?
|
Hematocrit | 1 | 2009 | 622 | 0.020 |
Why?
|
Bronchiectasis | 1 | 2009 | 141 | 0.020 |
Why?
|
Health Personnel | 1 | 2021 | 3385 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2014 | 1258 | 0.020 |
Why?
|
Magnetite Nanoparticles | 1 | 2009 | 309 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2008 | 219 | 0.020 |
Why?
|
Chest Tubes | 1 | 2008 | 153 | 0.020 |
Why?
|
Infusion Pumps, Implantable | 1 | 2008 | 158 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2012 | 2227 | 0.020 |
Why?
|
Hepatic Artery | 1 | 2008 | 233 | 0.020 |
Why?
|
Iohexol | 1 | 2008 | 205 | 0.020 |
Why?
|
Proteinuria | 1 | 2010 | 606 | 0.020 |
Why?
|
Pyrimidines | 1 | 2019 | 3049 | 0.020 |
Why?
|
England | 1 | 2008 | 533 | 0.020 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2010 | 334 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2010 | 2543 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2009 | 358 | 0.020 |
Why?
|
Aortography | 1 | 2008 | 423 | 0.020 |
Why?
|
Pancreatitis | 1 | 2013 | 1086 | 0.020 |
Why?
|
Pancreatic Ducts | 1 | 2008 | 331 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2012 | 1195 | 0.020 |
Why?
|
Portal Vein | 1 | 2008 | 437 | 0.020 |
Why?
|
Esophagectomy | 1 | 2009 | 478 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5836 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2009 | 1835 | 0.010 |
Why?
|
Endometrial Neoplasms | 1 | 2014 | 1378 | 0.010 |
Why?
|
Gastrectomy | 1 | 2009 | 693 | 0.010 |
Why?
|
Administration, Oral | 1 | 2012 | 4016 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1777 | 0.010 |
Why?
|
Bone Density | 1 | 2016 | 3491 | 0.010 |
Why?
|
Perfusion | 1 | 2008 | 1408 | 0.010 |
Why?
|
Prospective Studies | 3 | 2014 | 54807 | 0.010 |
Why?
|
Cost Savings | 1 | 2008 | 900 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 17060 | 0.010 |
Why?
|
Gastroesophageal Reflux | 1 | 2009 | 834 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2014 | 2040 | 0.010 |
Why?
|
Water | 1 | 2008 | 1416 | 0.010 |
Why?
|
Body Weight | 1 | 2012 | 4627 | 0.010 |
Why?
|
Myelography | 1 | 1999 | 72 | 0.010 |
Why?
|
Louisiana | 1 | 1999 | 104 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 1999 | 370 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2009 | 1961 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41680 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2014 | 4044 | 0.010 |
Why?
|
Premature Birth | 1 | 2010 | 1830 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 2010 | 1943 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2016 | 15802 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2009 | 3360 | 0.010 |
Why?
|
Uterus | 1 | 2000 | 660 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10727 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23597 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4037 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30192 | 0.010 |
Why?
|
Anticoagulants | 1 | 2008 | 4856 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 12235 | 0.000 |
Why?
|
Pregnancy | 1 | 2010 | 30230 | 0.000 |
Why?
|
Graft Survival | 1 | 1999 | 3904 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13631 | 0.000 |
Why?
|
HIV Infections | 1 | 2010 | 17531 | 0.000 |
Why?
|